PAPER Burnes DP, Burnette D
SEARCH RESULTS
329940 RESULTS
PAPER Wildsmith KR, Holley M, Savage JC, Skerrett R, Landreth GE
Evidence for impaired amyloid β clearance in Alzheimer's disease.
Alzheimers Res Ther. 2013 Jul 12;5(4):33. PubMed: 23849219PAPER Zilkens RR, Duke J, Horner B, Semmens JB, Bruce DG
Australian population trends and disparities in cholinesterase inhibitor use, 2003 to 2010.
Alzheimers Dement. 2013 Jul 9; PubMed: 23849590PAPER Verlinden VJ, van der Geest JN, Hofman A, Ikram MA
Cognition and gait show a distinct pattern of association in the general population.
Alzheimers Dement. 2013 Jul 9; PubMed: 23849591PAPER Solomon A, Ngandu T, Soininen H, Hallikainen MM, Kivipelto M, Laatikainen T
Validity of dementia and Alzheimer disease diagnoses in Finnish national registers.
Alzheimers Dement. 2013 Jul 9; PubMed: 23849592PAPER Blom K, Emmelot-Vonk MH, Koek HL
The influence of vascular risk factors on cognitive decline in patients with dementia: A systematic review.
Maturitas. 2013 Oct;76(2):113-7. PubMed: 23849703PAPER Zhang J, Cao Q, Li S, Lu X, Zhao Y, Guan JS, Chen JC, Wu Q, Chen GQ
3-hydroxybutyrate methyl ester as a potential drug against Alzheimer's disease via mitochondria protection mechanism.
Biomaterials. 2013 Oct;34(30):7552-62. PubMed: 23849878PAPER Phillips NR, Simpkins JW, Roby RK
Mitochondrial DNA deletions in Alzheimer's brains: A review.
Alzheimers Dement. 2013 Jul 11; PubMed: 23850329PAPER Lista S, Garaci FG, Ewers M, Teipel S, Zetterberg H, Blennow K, Hampel H
CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease.
Alzheimers Dement. 2013 Jul 11; PubMed: 23850330PAPER Hamilton JM, Salmon DP, Raman R, Hansen LA, Masliah E, Peavy GM, Galasko D
Accounting for functional loss in Alzheimer's disease and dementia with Lewy bodies: Beyond cognition.
Alzheimers Dement. 2013 Jul 11; PubMed: 23850331PAPER Hausner L, Tschäpe JA, Schmitt HP, Hentschel F, Hartmann T, Frölich L
Clinical characterization of a presenilin 1 mutation (F177S) in a family with very early-onset Alzheimer's disease in the third decade of life.
Alzheimers Dement. 2013 Jul 11; PubMed: 23850332PAPER Henriksen K, O'Bryant SE, Hampel H, Trojanowski JQ, Montine TJ, Jeromin A, Blennow K, Lönneborg A, Wyss-Coray T, Soares H, Bazenet C, Sjögren M, Hu W, Lovestone S, Karsdal MA, Weiner MW,
The future of blood-based biomarkers for Alzheimer's disease.
Alzheimers Dement. 2013 Jul 11; PubMed: 23850333PAPER Wicklund MR, Duffy JR, Strand EA, Whitwell JL, Machulda MM, Josephs KA
Aphasia with left occipitotemporal hypometabolism: A novel presentation of posterior cortical atrophy?
J Clin Neurosci. 2013 Sep;20(9):1237-40. PubMed: 23850398PAPER Windisch M, Flunkert S, Havas D, Hutter-Paier B
Commentary to the recently published review "Drug pipeline in neurodegeneration based on transgenic mice models of Alzheimer's disease" by Li, Evrahimi and Schluesener. Ageing Res. Rev. 2013 Jan;12(1):116-40.
Ageing Res Rev. 2013 Jul 10;12(4):852-854. PubMed: 23851053PAPER Mesulam MM
Cholinergic circuitry of the human nucleus basalis and its fate in alzheimer's disease.
J Comp Neurol. 2013 Jul 13; PubMed: 23852922Current Filters
No filters selected